The study of Yasuda et al. (106) revealed that normal human cervix and endometrium, as well as ovary malignant tumors of female reproductive organs produce EPO and EPOR, and that the tumor cells themselves and capillary endothelial cells are sites responsive to the EPO signal. The gene discussed is EPO; the disease is female reproductive organ cancer.